SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency (Q38415523)
Jump to navigation
Jump to search
scientific article published on 13 February 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency |
scientific article published on 13 February 2015 |
Statements
1 reference
SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency (English)
1 reference
Susan Sorrells
1 reference
Sandra Camprubi
1 reference
Rhonda Griffin
1 reference
Junliang Chen
1 reference
Jaume Ayguasanosa
1 reference
13 February 2015
1 reference
1 reference
109
1 reference
4
1 reference
490-499
1 reference
Identifiers
1 reference
1 reference